Testing effectiveness (Phase 2)Study completedNCT00174941What this trial is testingLong-Term Safety of Febuxostat in Subjects With Gout.Who this might be right forGout Takeda 116
Early research (Phase 1)Study completedNCT05168683What this trial is testingScintigraphy Study in Healthy Volunteers to Characterize the Performance of ALLN-346 TabletsWho this might be right forHyperuricemiaGout Allena Pharmaceuticals 12
Not applicableStudy completedNCT01685424What this trial is testingEtoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1)Who this might be right forOsteoarthritisRheumatoid ArthritisAnkylosing Spondylitis+2 more Organon and Co 79,189
Testing effectiveness (Phase 2)Study completedNCT06056570What this trial is testingOpen Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With HyperuricemiaWho this might be right forGoutHyperuricemia Urica Therapeutics Inc. 20
Not applicableStudy completedNCT05607797What this trial is testingGenetic of Chronic Kidney Disease and Gout in New CaledoniaWho this might be right forGoutRenal Insufficiency, Chronic Lille Catholic University 1,858
Large-scale testing (Phase 3)Study completedNCT00829829What this trial is testingPREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1Who this might be right forIntercritical Gout Regeneron Pharmaceuticals 241
Testing effectiveness (Phase 2)Active Not RecruitingNCT07116746What this trial is testingEvaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed PatientsWho this might be right forGoutGouty ArthritisHyperuricemia+4 more Arthrosi Therapeutics 15
Testing effectiveness (Phase 2)Study completedNCT02330796What this trial is testingBucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe GoutWho this might be right forGout Revive Therapeutics, Ltd. 66
Not applicableUnknownNCT03038386What this trial is testingDiagnostic Value of DECT Scan Compared to Diagnostic Needle AspirationWho this might be right forGout Meander Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT00985127What this trial is testingStudy to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With GoutWho this might be right forGout BioCryst Pharmaceuticals 99
Not applicableNot Yet RecruitingNCT07061587What this trial is testingDeveloping A Gout Action Plan in Primary Care Setting in SingaporeWho this might be right forGout; HyperuricemiaGout FlareGout Chronic SingHealth Polyclinics 72
Testing effectiveness (Phase 2)Looking for participantsNCT07535034What this trial is testingTrial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout ParticipantsWho this might be right forGout Crystalys Therapeutics 90
Not applicableStudy completedNCT04849312What this trial is testingPrediction of 30-Day Readmission Using Machine LearningWho this might be right forInfectionHeart FailureChronic Obstructive Pulmonary Disease+6 more Brigham and Women's Hospital 372
Early research (Phase 1)Study completedNCT06258213What this trial is testingEvaluate the Safety, Tolerability, and Pharmacokinetics of Oral ABP-745 Administration in Healthy VolunteersWho this might be right forGoutAcute Gout FlareGout Flares Atom Therapeutics Co., Ltd 90
Not applicableLooking for participantsNCT06971146What this trial is testingNurse-Led Telehealth for GoutWho this might be right forHealth LiteracyGout ArthritisGout Initiating Urate-loweringUrate-lowering Therapy+3 more University of Aarhus 200
Not applicableStudy completedNCT02471261What this trial is testingElastography as Gouty Arthropathy Outcome (EGO)Who this might be right forGout Arthritis & Rheumatism Associates, P.C. 10
Early research (Phase 1)Study completedNCT02219516What this trial is testingMild, Moderate and Severe Renal Impairment StudyWho this might be right forGout Ardea Biosciences, Inc. 31
Large-scale testing (Phase 3)Study completedNCT00856206What this trial is testingReview of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE)Who this might be right forGout Regeneron Pharmaceuticals 1,315
Not applicableStudy completedNCT01151709What this trial is testingAssessment of Primary Care Providers' Knowledge and Beliefs Regarding Gout ManagementWho this might be right forGout University of Massachusetts, Worcester 838
Not applicableLooking for participantsNCT06092346What this trial is testingA Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism DisordersWho this might be right forAMPD3, OMIM*102772, AMP Deaminase DeficiencyAK1, OMIM *103000, Adenylate Kinase DeficiencyAMPD1, OMIM *102770, Myopathy Due to Myoadenylate Deaminase Deficiency+25 more National Human Genome Research Institute (NHGRI)